• No se han encontrado resultados

[PDF] Top 20 Depressão, qualidade de vida em idosos institucionalizados

Has 10000 "Depressão, qualidade de vida em idosos institucionalizados" found on our website. Below are the top 20 most common "Depressão, qualidade de vida em idosos institucionalizados".

PELEGRINA

Parkinson's disease: carbidopa, nausea, and dyskinesia

... nausea, utilizing the same basic chemical mechanism as carbidopa and benserazide: AADC inhibition. Carbidopa and benserazide inhibition is irreversible while 5-HTP inhibi- tion is reversible. The use ... See full document

8

Diagnóstico presuntivo de dengue en pacientes con fiebre y serología reactiva ingresados en un hospital pediátrico

Carbidopa/levodopa/entacapone: the evidence for its place in the treatment of Parkinson’s disease

... “severe”. Nausea was the most com- mon with a trend to be more frequent in the CLE group (14% versus ...whereas dyskinesia was more common in the CLE group (7% versus ... See full document

10

BASES GENERALES DE LA CONVOCATORIA PARA LA REAPERTURA DE LA BOLSA DE TRABAJO DE EDUCADOR/A PARA LA ESCUELA INFANTIL MUNICIPAL PAPÁ PITUFO

Optimizing levodopa therapy for Parkinson’s disease with levodopa/carbidopa/entacapone: implications from a clinical and patient perspective

... Levodopa/carbidopa/entacapone is a pharmacokinetically optimized levodopa formulation that offers more consistent plasma levodopa levels without deep troughs. Clinical evi- dence in PD patients experiencing motor ... See full document

7

QUÉ ES Y PARA QUÉ SIRVE UN CÓDIGO DE ÉTICA?

<p>The Advantages of Levodopa-Carbidopa Intestinal Gel for Patients with Advanced Parkinson&rsquo;s Disease: A Systematic Review</p>

... ed Parkinsons Disease Rating Scale) in 4 trials, PDQ-39 (39-item Parkinsons Disease Questionnaire) in 2 trials, “ off ” time in 2 trials, on- time with troublesome ... See full document

12

ESTUFA DE BIOMASA MODELO SIERRA

Profile of levodopa/carbidopa intestinal gel and its potential in the treatment of advanced Parkinson&#39;s disease

... Parkinson’s disease (PD) is characterized by a progression of symptoms in the course of time which typically leads to the occurrence of motor complications in the advanced stages of ...stimulation, ... See full document

9

DIRECCIÓN GENERAL DE EDUCACIÓN TECNOLÓGICA INDUSTRIAL. Programa de Mejora Continua. Centro de Estudios Tecnológicos Industrial y de Servicios No.

The role and structure of the multidisciplinary team in the management of advanced Parkinson&rsquo;s disease with a focus on the use of levodopa&ndash;carbidopa intestinal gel

... of disease man- agement, for example, with therapy decisions, which can become more complex as the disease ...their disease, provide unbiased information and advice as and when appropriate, tailoring ... See full document

29

NewsLetter Q Cómo mejorar su negocio

Intrastriatal injections of KN-93 ameliorates levodopa-induced dyskinesia in a rat model of Parkinson&rsquo;s disease

... intrastriatal KN-93 treatment reduced levodopa-induced dyskinesia in PD rats As shown in Figure 3, increased AIMs scores in PD rats were observed in PD rats after administrati[r] ... See full document

7

Ricardo Miralles. Reseñas de libros 329

Effects of blackberry (<em>Morus nigra</em>) fruit juice on levodopa-induced dyskinesia in a mice model of Parkinson&#39;s disease

... The first evaluation was carried out on the second day of the study. Average score of AIMS test in all groups was nearly the same indicating that no changes in motor func- tion behaviors happened (control group 0.13 ± ... See full document

8

LA IGLESIA DE JESUCRISTO DE LOS SANTOS DE LOS ULTIMOS DIAS (MORMONES)

Amantadine extended-release capsules for levodopa-induced dyskinesia in patients with Parkinson&#39;s disease

... The UDysRS total score in the patients receiving aman- tadine improved significantly by 20.7 points at 12 weeks compared with baseline. When compared with placebo, a difference of 14.4 points ( p,0.0001) was found. The ... See full document

5

Sistema Configurable A medida WIRELESS ATEX &amp; IECEX

Levodopa/carbidopa/entacapone versus levodopa/dopa-decarboxyiase inhibitor for the treatment of Parkinson&#39;s disease: systematic review, meta-analysis, and economic evaluation

... We searched PubMed, Embase, Cochrane Central Register of Controlled Trials, and three Chinese databases – WanFang Data, Chinese Science and Technology Journal Database, and China National Knowledge Infrastructure – from ... See full document

11

D ssier de empresa. tu CENTRO. de IDIOMAS en NERVIÓN

Review: management of Parkinson&#39;s disease

... Two methods are available: (1) subcutaneous apomorphine injections “on demand;” or (2) continuous subcutaneous injection by means of a pump. Both forms might cause side effects, the most frequent being nausea and ... See full document

12

PRIMERA.- NORMAS GENERALES.

Rasagiline in treatment of Parkinson&rsquo;s disease

... Subjects were randomly assigned to either 1 mg/day rasagiline, 200 mg entacapone with every levodopa dose, or placebo. Levodopa dosage could be reduced in the initial 6 weeks but no change could be made subsequently. The ... See full document

7

PROSPECTO SIMPLIFICADO IF II OPCIÓN ESTRATÉGICA SOLES FMIV

Von Economo&rsquo;s disease and postencephalitic parkinsonism responsive to carbidopa and levodopa

... Abbreviations: WBC, white blood cell; rBC, red blood cell; MCV, mean corpuscular volume; MCH, mean corpuscular hemoglobin; rDW, red blood cell distribution width; pLT, platelet; BUN, blood urea nitrogen; asT, aspartate ... See full document

10

FONDO MUTUO RENTA FIJA BHD FONDOS PLAZO 30 DÍAS DÓLARES

Onset and duration of effect of extended-release carbidopa-levodopa in advanced Parkinson&rsquo;s disease

... All patients had been taking commercially available IR CD-LD at least four times/day (excluding nighttime dosing), with a levodopa dosage totaling 500–1,600 mg/day, in a regimen that had been stable for at least 1 month. ... See full document

56

¿Una ontologí­a dinámica en la ética a Nicómaco?

Practice Parameter: Treatment of Parkinson disease with motor fluctuations and dyskinesia (an evidence-based review): [RETIRED]Report of the Quality Standards Subcommittee of the American Academy of Neurology

... and dyskinesia, magnitude of response, adverse events, and levodopa dose ...AND Parkinson disease; DBS AND Par- kinson disease; subthalamic stimulation AND Par- kinson disease; pallidal ... See full document

24

LA CAPACITACION COMO HERRAMIENTA DE PREVENCION DE RIESGOS EN EL TRABAJO. Dirección de Movilidad y Formación para el Trabajo

Levodopa/carbidopa and entacapone in the treatment of Parkinson&rsquo;s disease: efficacy, safety and patient preference

... with carbidopa (CD) and the catechol-O-methyltransferase (COMT) inhibitor entacapone (EN) may reduce the onset of these motor complications to a certain ...Parkinson’s disease, preference, compliance, ... See full document

12

BASES LLAMADO A CONCURSO PÚBLICO DE ANTECEDENTES PARA PROVEER CARGO DE ASISTENTE O TRABAJADOR SOCIAL EN CALIDAD DE TITULAR DE LA PLANTA PROFESIONAL

Ranitidine reduced levodopa-induced dyskinesia in a rat model of Parkinson&rsquo;s disease

... with levodopa induced full LID expression in PD rats, includ- ing axial, forelimb, orolingual, and locomotor dyskinesia, as demonstrated by increased AIMS over 22 days. Acute admin- istration of ranitidine had no ... See full document

8

LUIS RAMIRO ESCANDÓN HERNÁNDEZ

Parkinson&rsquo;s disease psychosis

... Parkinson’s disease is a progressive neurodegenerative disease characterized by loss of nigral dopaminergic neurons associated with rigidity, resting tremor, bradykinesia, and postural ...Parkinson’s ... See full document

44

DECRETO 99/2004, de 9 de marzo, por el que se aprueba la revisión del Plan de Gestión de Residuos Peligrosos de Andalucía.

Study protocol of “CHAPS”: a randomized controlled trial protocol of Care Coordination for Health Promotion and Activities in Parkinson’s Disease to improve the quality of care for individuals with Parkinson’s disease

... initial Action Plan is orientation to the self-management healthcare notebook and a few priority problems that the Veteran and NCM collaboratively decide are the most important to work on. These Veteran-focused personal- ... See full document

131

Información financiera al 31 de diciembre del 2013

<p>Validation study of the Parkinson&rsquo;s Fatigue Scale in advanced Parkinson&rsquo;s disease</p>

... ’ s Parkinsons Disease Pain scale; and grant from the International Parkinson and Movement Disorder Society to attend the congress of the society in ... See full document

6

Show all 10000 documents...